Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Luoxin Pharmaceuticals Group
Luoxin Pharmaceuticals Group
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Luoxin Pharmaceuticals Group
Stock Price
¥4.8
2024-10-29
Market Capitalization
¥4.9 B
2024-10-29
Revenue
¥2.2 B
FY, 2025
Luoxin Pharmaceuticals Group Summary
Company Summary
Overview
Luoxin Pharmaceuticals Group (罗欣药业集团) is a company that produces and trades drugs. Its products include tablets, injections, capsules, medicine raw materials, etc.
Type
Public
Status
Active
Founded
2006
HQ
Linyi, CN
|
view all locations
Website
http://www.luoxin.cn
Cybersecurity rating
Sectors
Healthcare
drug development
pharma
Homepage
Table of Contents
Locations
Financials
Competitors
Locations
View all
1 location detected
Linyi, Shandong
HQ
China
Luoxin Pharmaceuticals Group Financials
Summary Financials
Revenue (Q1, 2026)
¥576.8M
Gross profit (Q1, 2026)
¥349.6M
Net income (Q1, 2026)
¥29.0M
Cash (Q1, 2026)
¥798.5M
EBIT (Q1, 2026)
¥41.3M
Enterprise value
$5.6B
Competitors and Similar Companies
McKesson Europe
Healthcare - Subsidiary
Alkem Laboratories
Healthcare - Public
Macleods Pharmaceuticals
Healthcare - Private
Sanofi Pasteur
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top